Breaking News
Investing Pro 0
👀 Bezos, Buffett & Berkowitz: What's in Their Portfolios? Unlock Data
Close

Moderna Inc (0QF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
117.0600 -0.1600    -0.14%
21:19:00 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US60770K1079 
S/N:  A2N9D9
  • Volume: 393
  • Bid/Ask: 117.0800 / 117.8400
  • Day's Range: 117.0600 - 119.2000
Moderna 117.0600 -0.1600 -0.14%

Moderna Inc Company Profile

 
Get an in-depth profile of Moderna Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

3900

Equity Type

ORD

Moderna, Inc. is a biotechnology company. The Company is focused on developing messenger ribonucleic acid (mRNA) therapeutics and vaccines. It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range spectrum of diseases. The Company's products include Spikevax, the Moderna COVID-19 vaccine (mRNA-1273), a bivalent vaccine targeting the BA.1 Omicron variant, combined with Spikevax (mRNA-1273.214), and bivalent vaccine targeting the BA.4/BA.5 Omicron variants combined with Spikevax (mRNA-1273.222). It has a development pipeline of 45 development candidates across its 48 development programs, of which 38 are in clinical studies.

Contact Information

Address 200 Technology Square
Cambridge, 02139
United States
Phone 617 714 6500
Fax -

Top Executives

Name Age Since Title
Robert S. Langer 73 2010 Independent Non Executive Director & Member of Scientific Advisory Board
Jack W. Szostak - 2014 Chairman of Scientific Advisory Board
Elizabeth Edith Tallett 72 2020 Independent Director
Scott A. Canute 61 2014 Member of Technology Advisory Board
Ulrich H. von Andrian-Werburg - - Member of Scientific Advisory Board
Fred E. Regnier - 2014 Member of Technology Advisory Board
Richard C. Willson - 2014 Member of Technology Advisory Board
John G. Aunins 61 2014 Member of Technology Advisory Board
James R. Swartz - 2014 Member of Technology Advisory Board
Sandra J. Horning 73 2020 Independent Director
Elizabeth G. Nabel 70 2021 Independent Director
Noubar B. Afeyan 60 2010 Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
Stephane Bancel 50 2011 CEO & Director
Melissa J. Moore - 2016 Chief Scientific Officer & Member of Scientific Advisory Board
Ron Eydelloth - - Member of Scientific Advisory Board
Rachel Green - - Member of Scientific Advisory Board
Paul L. Sagan 64 2018 Independent Non Executive Director
Ralph Weissleder - - Member of Scientific Advisory Board
Paula T. Hammond 59 - Member of Scientific Advisory Board
Michael Diamond - - Member of Scientific Advisory Board
Stephen A. Berenson 62 2017 Independent Non Executive Director
Francois Nader 66 2019 Independent Non Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email